Restoring quality of life and independence in daily living activities
Streetlab is involved in several projects covering the rehabilitation of people affected by visual impairment. The objectives are:
• propose rehabilitation methods complementary to existing techniques
• help those people concerned to make use of therapeutic or palliative innovations (artificial retina, optogenetics, etc.).
• measuring the therapeutic benefit of these treatments or medical interventions
Experts in physiotherapy also participate in this work.
Work within clinical studies
Implementation and validation of rehabilitation protocols
Protocols based on daily living activities
Adaptation of protocols in relation to visual deficits and the extent of damage
Innovative technology platforms
Scientific and objective rigour
Iris 1 and Sight Again
The objective of these projects is to restore the vision of blind people affected by retinitis pigmentosa by the implantation of an artificial retina (Iris 1 or Prima developed by Pixium Vision) or by optogenetic gene therapy (GS030 created by Gensight Biologics ).
The role of the Streetlab team is twofold:
• Help patients understand and interpret the visual perceptions generated by these products and teach them visual and cognitive strategies so as to discover, analyse and interact with their environment.
• Measure, through evaluation protocols, the impact of these products on the daily lives of the patients.
The sessions are organised in our controlled test environment called the ‘Artificial street’.
Our collaborators in this clinical, academic and industrial research: Dr Mohand-Saïd (Clinical Investigation Centre of the Quinze-vingts Hospital), Serge Picaud (Research Director at the Vision Institute) and Ryad Benosman (Research Director at INSERM, Pixium Vision and Gensight Biologics).